
Anger over slashing of ICU beds
The number of intensive care unit beds planned for Dunedin's new hospital on opening has been slashed by a third, the Otago Daily Times has learned.
The proposal has angered former head of Dunedin Hospital's emergency department Dr John Chambers, who said it could lead to pressure on the wider hospital network and surgery delays.
Documents released under the Official Information Act show that on January 23 this year, Health New Zealand Te Whatu Ora (HNZ) infrastructure lead Blake Lepper told then Health Minister Dr Shane Reti it planned to reduce the number of ICU beds on opening from 30 to 20.
The reduction in ICU beds was not made public when new Health Minister Simeon Brown visited Dunedin on January 31 to announce it was building a scaled-back hospital at the former Cadbury's site for $1.88 billion.
Mr Lepper confirmed to the Otago Daily Times yesterday HNZ was going ahead with the reduction in ICU beds on opening.
Dr Chambers said reducing the number of ICU beds would have significant impacts on the rest of the hospital.
"The reason for building a new hospital was the inadequacy of the current buildings.
"The aim is to have sufficient capacity to serve the needs of our population for the next 50 years and avoid the problems of our current system, such as elective basic surgery being cancelled due a lack of ward beds or complex surgery due to a lack of ICU beds."
Mr Lepper's briefing also conceded that officials' new proposal would have fewer inpatient beds than initially proposed, but said the capacity "meets forecast demand requirements on opening".
"It provides more beds than are presently resourced, but less than the current hospital physical capacity.
"The approach is aligned with the Australian state of Victoria and validation has also been made against the Queensland state approach."
The existing Dunedin Hospital has a 388-bed tertiary facility capacity.
Mr Brown announced the new hospital will open with 351 inpatient beds — 59 fewer than originally proposed, but with capacity to expand to 404 beds over time.
Dr Chambers said health officials seemed to have been tasked with "retrospectively downsizing the plans across the board in response to projected increasing costs".
"The aim should be a staffed facility including an ICU where the cancellation of elective surgery including neurosurgery and cardiac surgery is a very rare event."
Mr Lepper said yesterday the number and makeup of bed spaces at the new Dunedin hospital had been guided by more up-to-date bed modelling analysis for the southern region.
"This has resulted in some adjustments in capacity for different areas to align with the most recent assessment of expected demand."
The new Dunedin hospital will have 20 ICU beds on opening, with capacity to increase to 40 ICU beds over time, he said.
The original plan was for 30 ICU beds on opening, and capacity for a further 10 beds.
"The bed spaces earmarked for future fitout have been informed by the modelling and current thinking about models of care."
Dr Chambers said the officials' correspondence made for grim reading.
"The main message I took from the limited information was just how tight the
new facility is going to be in terms of its size and bed numbers.
"There are fewer inpatient beds than the current hospital, and it's very dependent on new models of care to reduce the need for hospital care and deliver care using an ambulatory /same day model.
Last year, the ODT revealed HNZ officials considered removing the sixth floor, which would have housed the psychogeriatric and dementia wing, from the new Dunedin hospital — but in January this year, HNZ officials proposed the sixth floor be "shelled" for future development.
Dr Chambers was pleased the sixth floor remained, but said any sort of expansion "could take many years".
"There certainly will be the capacity to do a lot more surgery and procedures if all the additional theatres are staffed and functioning.
"So, when the new hospital finally opens in five-plus years, it will be a nervous time to see how it copes with increasing the service delivery which our population needs and deserves."
matthew.littlewood@odt.co.nz
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Scoop
2 hours ago
- Scoop
Do I Have To Pay For My Partner's Care?
Send your questions to If one person in a de facto relationship needs permanent medical care, does the Government require the other partner to pay for the care once the unwell patient's funds run out? The basic answer to your question is that when your partner is being assessed for their ability to pay for their care, your income and assets will usually be taken into account. If you're referring to medical care in a rest home setting, your assets and personal income affect whether your partner will qualify for a residential care subsidy. "People who need residential care are required to pay for it themselves, if they can afford to do so. If they cannot afford it, they may be eligible for a residential care subsidy, which Health New Zealand pays directly to the care provider," said Ministry of Social Development group general manager for client service delivery Graham Allpress. "MSD's role is to check whether people qualify for this subsidy by performing a 'financial means assessment'. "To get the subsidy, a person's income and assets must be under a certain amount. If they are in a relationship, the combined income and assets of both parties must be under a certain amount." People can qualify for the subsidy if they are 50 to 64, single and without dependent children, or over 65 and meet the income and means test. That means, even if your partner's funds have run out, your assets could still be taken into account. If only one partner needs care, the couple combined need to have assets of no more than $155,873 not including the family home and car, or $284,636 if you do want the home and car in the assessment. If it's other types of care that you're thinking of, it could be a good idea to contact Health NZ for a needs assessment. There are options such as the supported living payment but eligibility for this is assessed on a household income basis, too. I'm currently a NZ tax resident living in NZ, but previously lived in Australia (over a decade ago) and purchased shares on the ASX that I continue to own and receive dividends for (which I declare as part of my income). If I sold these shares now, worth about $150,000, what taxes would they be subject to? Specifically, would I have to pay a capital gains tax on the increased share value (as I would if I were an Australian tax resident). This is probably a question for an accountant with expertise in Australian tax. Based on information available online, it seems that you potentially should have paid tax on the shares in Australia when you stopped being an Australian resident. Assuming that didn't happen, the Australian Tax Office is likely to be expecting capital gains tax to be paid on them when they are sold. You aren't likely to have any New Zealand tax obligations. Tax experts tell me that the authorities have access to a lot of data these days so it's possible that the Australian Tax Office will find out about any share sale and might get in touch with you. I am 78 years of age and still work part time and also still contribute to my KiwiSaver. Am I eligible for the government contribution? Sorry, no. While the government said it was going to start making contributions to 16 and 17-year-olds' accounts, it hasn't budged on the upper limit of 65.


Otago Daily Times
12 hours ago
- Otago Daily Times
Ceres working at new hospital site
Photo: Gregor Richardson Contractors from Christchurch-based construction company Ceres work on the site of the new Dunedin hospital inpatient building on Thursday. Ceres was contracted to demolish and dispose of waste from the site's previous buildings and install piles for the new building. In late September, the government told the public it was pausing the new Dunedin hospital project to decide whether to continue with a scaled-back version of it, or retrofit the existing hospital. Tenders for the substructure works on the inpatient building were expected to be issued in late June with work to begin in September. A Health New Zealand Te Whatu Ora spokesman said this week's activity was "business as usual".


Scoop
a day ago
- Scoop
St Vincent's Hospital Melbourne Signs Agreement With NZ MedTech Veriphi To Boost Medication Safety For Cancer Patients
Press Release – Veriphi The agreement marks the first commercial hospital contract for Veriphi, which has spent more than a decade developing an innovative analyser that uses laser spectrometry, AI and cloud computing to verify the identity and concentration of IV drugs in real … St Vincent's Hospital Melbourne has signed a 12-month supply agreement with New Zealand MedTech company Veriphi, to deploy its breakthrough intravenous medication verification technology in the hospital's sterile oncology compounding pharmacy. The agreement marks the first commercial hospital contract for Veriphi, which has spent more than a decade developing an innovative analyser that uses laser spectrometry, AI and cloud computing to verify the identity and concentration of IV drugs in real time. The goal: reduce preventable harm from medication errors and improve dosing accuracy for vulnerable cancer patients. St Vincent's Hospital Melbourne, a tertiary public healthcare provider with more than 880 beds and over 5,000 staff, is part of St Vincent's Health Australia – the country's largest not for-profit health and aged care provider. 'St Vincent's Hospital Melbourne is excited to be working with technology company Veriphi to improve medication safety in our sterile oncology compounding pharmacy,' said Andrew Cording, Chief Pharmacist from St Vincent's. 'The safety of our patients, including medication safety, is a top priority for St Vincent's, so we are proud to be working with world-leading technology.' The agreement reflects a shared commitment to innovation and safety in cancer care, with Veriphi's system designed to support pharmacists and clinical staff in verifying complex, high-risk medications. 'We are delighted to be working with St Vincent's Hospital Melbourne,' said Greg Shanahan, Managing Director of Veriphi. 'Our values regarding the protection of patient safety from medication error align perfectly with St Vincent's. We are proud to collaborate with an organisation whose culture and focus on patient outcomes are supported by Veriphi's breakthrough technology.' Medication errors remain one of the most serious – and preventable – threats to patient safety worldwide. Intravenous drugs, particularly those used in oncology, require precise handling and verification to avoid harm. Veriphi's analyser brings a new layer of safety, enabling hospitals to verify each dose at the point of compounding before administration to patients. The St Vincent's partnership marks a major milestone for Veriphi's commercial rollout, with further expansion plans underway across Australia, New Zealand, and the United States. Veriphi is currently raising funds to expand its impact around the globe. New Zealand and Australian residents can invest at